<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30247970</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1557-7708</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>24</Volume>                    <Issue>9-10</Issue>                    <PubDate>                        <MedlineDate>2018 Sep/Oct</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>Journal of alternative and complementary medicine (New York, N.Y.)</Title>                <ISOAbbreviation>J Altern Complement Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Absent and Discordant Electronic Health Record Documentation of Complementary and Alternative Medicine in Cancer Care.</ArticleTitle>            <Pagination>                <MedlinePgn>988-995</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1089/acm.2018.0141</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Many patients with cancer use complementary and alternative medicine (CAM), but the quality of CAM documentation in their electronic health records (EHRs) is unknown. The authors aimed to describe (i) the prevalence and types of CAM used after cancer diagnosis and the influence of oncologists on CAM use, as per patients' self-report, and (ii) the prevalence of CAM documentation in the EHR and its consistency with self-reported usage.</AbstractText>                <AbstractText Label="DESIGN" NlmCategory="METHODS">Patient and provider surveys and chart review.</AbstractText>                <AbstractText Label="SETTINGS/LOCATION" NlmCategory="METHODS">Medical oncology practices at one institution.</AbstractText>                <AbstractText Label="SUBJECTS" NlmCategory="METHODS">Patients with cancer at oncologist visits.</AbstractText>                <AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Patient self-reported rate of 3-month postvisit CAM use; provider EHR documentation of CAM use or discussion and its concordance with patient self-report.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 327 patients enrolled, 248 responded to the 3-month postvisit survey. Of these, 158 reported CAM use after diagnosis (63.7%). CAM users were younger (p &lt; 0.001) and had a higher percentage of women (p = 0.03) than nonusers. Modalities most commonly used were supplements (62.6%), special diets (38.6%), chiropractor (28.4%), and massage (28.4%). CAM was used to improve well-being (68.7%), manage adverse effects (35.5%), and fight cancer (22.9%). Oncologists suggested CAM in 22.5% of instances of use. CAM use/discussion was documented for 58.2% of self-reported CAM users. Of the documented modalities, EHR and self-report were concordant for only 8.2%. CAM documentation was associated with physician provider (p = 0.03), older patients (p = 0.01), and treatment with radiation (p = 0.03) or surgery (p = 0.001). After adjusting for other factors, patients with breast cancer or &quot;other&quot; tumor category were four times more likely than patients with gastrointestinal cancer to have CAM use documentation (odds ratio [95% confidence interval]: 4.41 [1.48-13.10]; 3.76 [1.42-9.99], respectively).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most patients with cancer use CAM after diagnosis, yet EHR documentation is complete for very few. Oncologists should inquire about, document, and discuss CAM benefits and harm or refer patients to CAM specialists.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Stan</LastName>                    <ForeName>Daniela L</ForeName>                    <Initials>DL</Initials>                    <AffiliationInfo>                        <Affiliation>1 Division of General Internal Medicine, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wahner-Roedler</LastName>                    <ForeName>Dietlind L</ForeName>                    <Initials>DL</Initials>                    <AffiliationInfo>                        <Affiliation>1 Division of General Internal Medicine, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yost</LastName>                    <ForeName>Kathleen J</ForeName>                    <Initials>KJ</Initials>                    <AffiliationInfo>                        <Affiliation>2 Department of Health Sciences Research, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>O'Byrne</LastName>                    <ForeName>Thomas Jamie</ForeName>                    <Initials>TJ</Initials>                    <AffiliationInfo>                        <Affiliation>2 Department of Health Sciences Research, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Branda</LastName>                    <ForeName>Megan E</ForeName>                    <Initials>ME</Initials>                    <AffiliationInfo>                        <Affiliation>2 Department of Health Sciences Research, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Leppin</LastName>                    <ForeName>Aaron L</ForeName>                    <Initials>AL</Initials>                    <AffiliationInfo>                        <Affiliation>2 Department of Health Sciences Research, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tilburt</LastName>                    <ForeName>Jon C</ForeName>                    <Initials>JC</Initials>                    <AffiliationInfo>                        <Affiliation>1 Division of General Internal Medicine, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>3 Biomedical Ethics Research Program, Mayo Clinic , Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>4 Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery , Mayo Clinic, Rochester, Minnesota.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Altern Complement Med</MedlineTA>            <NlmUniqueID>9508124</NlmUniqueID>            <ISSNLinking>1075-5535</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Biomed Inform. 2009 Apr;42(2):377-81</RefSource>                <PMID Version="1">18929686</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Care (Basel). 2014 Feb;9(1):60-3</RefSource>                <PMID Version="1">24803889</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Patient Educ Couns. 2015 Apr;98(4):512-7</RefSource>                <PMID Version="1">25636694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Fam Pract. 1999 Jun;48(6):459-63</RefSource>                <PMID Version="1">10386490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2000 Jul;18(13):2505-14</RefSource>                <PMID Version="1">10893280</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Altern Complement Med. 2008 Dec;14(10):1263-9</RefSource>                <PMID Version="1">19032071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1997 Jan;15(1):401-6</RefSource>                <PMID Version="1">8996167</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2013;2013:318781</RefSource>                <PMID Version="1">23606877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1998 Feb;34(3):324-8</RefSource>                <PMID Version="1">9640216</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Complement Altern Med. 2014 Dec 03;14:463</RefSource>                <PMID Version="1">25465676</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gerontol A Biol Sci Med Sci. 2002 Apr;57(4):M223-7</RefSource>                <PMID Version="1">11909887</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AMIA Annu Symp Proc. 2015 Nov 05;2015:1361-70</RefSource>                <PMID Version="1">26958277</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2013 Oct 04;13:455</RefSource>                <PMID Version="1">24093624</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Geriatr Oncol. 2015 Sep;6(5):411-7</RefSource>                <PMID Version="1">26277113</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg. 2000 May;179(5):407-11</RefSource>                <PMID Version="1">10930491</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mayo Clin Proc. 1999 May;74(5):443-7</RefSource>                <PMID Version="1">10319072</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 Oct;117(3):653-65</RefSource>                <PMID Version="1">19184414</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Complement Ther Med. 2013 Apr;21 Suppl 1:S10-9</RefSource>                <PMID Version="1">23578912</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000529" MajorTopicYN="Y">Complementary Therapies</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>                <QualifierName UI="Q000656" MajorTopicYN="N">utilization</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName>                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008910" MajorTopicYN="N">Minnesota</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">CAM</Keyword>            <Keyword MajorTopicYN="N">EHR</Keyword>            <Keyword MajorTopicYN="N">complementary and alternative medicine</Keyword>            <Keyword MajorTopicYN="N">oncology</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>09</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30247970</ArticleId>            <ArticleId IdType="doi">10.1089/acm.2018.0141</ArticleId>            <ArticleId IdType="pmc">PMC6157347</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>